Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation
Barbara Ann Karmanos Cancer Institute
Barbara Ann Karmanos Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Alliance for Clinical Trials in Oncology
Northwestern University
Case Comprehensive Cancer Center